Mediscribe Consulting Limited in Nottingham, NG2 6ND

Description

Data updated on: 01-11-2023

Mediscribe Consulting came into being in 2006 as a company enlisted under no 05764092, located at NG2 6ND Nottingham at 25 Coniston Close. This company has been in business for eighteen years and its current status is active. This company's classified under the NACE and SIC code 74909 and their NACE code stands for Other professional, scientific and technical activities not elsewhere classified. 2023-02-28 is the last time when account status updates were filed.

Rebecca T. is the enterprise's only managing director, who was selected to lead the company on 2006-04-18. Moreover, the director's responsibilities are constantly supported by a secretary - Paul S., who was chosen by the following company on 2006-04-18.

Rebecca T. is the individual who has control over this firm, owns over 3/4 of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-04-30	2012-04-30	2013-04-30	2014-04-30	2015-04-30	2016-02-29	2017-02-28	2018-02-28	2019-02-28	2020-02-29	2021-02-28	2022-02-28	2023-02-28
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	58 624	62 317	76 348	104 046	98 381	99 767

Balance Sheet
Current Assets	90 364	84 711	104 913	124 215	104 161	99 091	65 881	49 307	28 679	16 047	33 274	24 521	31 780
Cash Bank In Hand	74 214	73 452	25 544	5 109	7 160
Debtors	16 150	11 259	15 531	22 105	0	16 886
Net Assets Liabilities Including Pension Asset Liability	58 624	62 317	76 348	104 046	98 381
Tangible Fixed Assets	1 302	16 118	12 960	9 720	7 290	676
Intangible Fixed Assets					7 290

Capital & Reserves
Called Up Share Capital	1	1	1	1	1	1
Profit Loss Account Reserve	58 623	62 316	76 347	104 045	98 380	99 766
Shareholder Funds	58 624	62 317	76 348	104 046	98 381	99 767

Other Financial Data
Secured Debts	0	10 304	7 969	0
Total Fixed Assets Additions		20 190	1 163
Total Fixed Assets Cost Or Valuation	3 382	23 572	24 735	24 735	24 735
Total Fixed Assets Depreciation	2 080	7 454	11 775	15 015	17 445
Total Fixed Assets Depreciation Charge In Period		5 374	4 321	3 240	2 430
Accrued Liabilities Not Expressed Within Creditors Subtotal							600	1 000	1 000	1 000	1 000	1 000	1 000
Average Number Employees During Period							2	1	1	1	1	1	1
Creditors							7 433	12 275	14 500	15 135	22 312	17 766	20 034
Fixed Assets	1 302	16 118	12 960	9 720	7 290	676	507	380	285	197	1 512	1 134	1 243
Net Current Assets Liabilities	57 322	56 503	71 357	94 326	91 091	99 091	58 448	37 032	14 179	912	10 962	6 755	11 746
Total Assets Less Current Liabilities	58 624	72 621	84 317	104 046	98 381	99 767	58 955	37 412	14 464	1 109	12 474	7 889	12 989
Advances Credits Directors					42	16 886	277	1 870	959	9 155	1 701	96
Advances Credits Made In Period Directors						18 976	68 197		81 452	81 364	61 406
Advances Credits Repaid In Period Directors						2 048	85 360		80 540	71 250	72 262
Creditors Due After One Year Total Noncurrent Liabilities	0	10 304	7 969	0
Creditors Due Within One Year Total Current Liabilities	33 042	28 208	33 556	29 889	13 070
Investments Current Assets			63 838	97 001	97 001
Tangible Fixed Assets Additions		20 190	1 163
Tangible Fixed Assets Cost Or Valuation	3 382	23 572	24 735	24 735	24 735	4 545
Tangible Fixed Assets Depreciation	2 080	7 454	11 775	15 015	17 445	3 869
Tangible Fixed Assets Depreciation Charge For Period		5 374	4 321	3 240	2 430
Cash Bank					7 160	93
Creditors Due Within One Year					13 070
Current Asset Investments					97 001	82 112
Number Shares Allotted					1	1
Number Shares Authorised						100
Par Value Share						1
Share Capital Allotted Called Up Paid					-1	-1
Share Capital Authorised					-100	-100
Tangible Fixed Assets Depreciation Charged In Period						226
Tangible Fixed Assets Depreciation Decrease Increase On Disposals						13 802
Tangible Fixed Assets Disposals						20 190

Company staff

Paul S.

Role: Secretary

Appointed: 18 April 2006

Latest update: 13 February 2024

Rebecca T.

Role: Director

Appointed: 18 April 2006

Latest update: 13 February 2024

People with significant control

Rebecca T.

Notified on 6 April 2016

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	30 November 2024
Account last made up date	28 February 2023
Confirmation statement next due date	14 April 2024
Confirmation statement last made up date	31 March 2023

Annual Accounts 20 November 2016
Start Date For Period Covered By Report	2015-05-01
End Date For Period Covered By Report	29 February 2016
Date Approval Accounts	20 November 2016
Annual Accounts
Start Date For Period Covered By Report	2016-03-01
End Date For Period Covered By Report	28 February 2017
Annual Accounts
Start Date For Period Covered By Report	2017-03-01
End Date For Period Covered By Report	28 February 2018
Annual Accounts
Start Date For Period Covered By Report	2018-03-01
End Date For Period Covered By Report	28 February 2019
Annual Accounts
Start Date For Period Covered By Report	2019-03-01
End Date For Period Covered By Report	29 February 2020
Annual Accounts
Start Date For Period Covered By Report	2020-03-01
End Date For Period Covered By Report	28 February 2021
Annual Accounts
Start Date For Period Covered By Report	2021-03-01
End Date For Period Covered By Report	28 February 2022
Annual Accounts
Start Date For Period Covered By Report	2022-03-01
End Date For Period Covered By Report	28 February 2023

Mediscribe Consulting Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Paul S.

Rebecca T.

@uk Dormant Company Secretary Limited

@uk Dormant Company Director Limited

People with significant control

Rebecca T.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies